UK Markets closed

Wright Medical Group N.V. - Con (WMGIZ)


NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.400.00 (0.00%)
At close: 5:26PM EDT
People also watch
WMGIXGTIWXTLBTROVWCELGZ
Full screen
Previous close1.40
Open1.32
Bid0.00 x
Ask0.00 x
Day's range1.32 - 1.46
52-week range1.20 - 2.67
Volume21
Avg. volume60,912
Market capN/A
BetaN/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Wright Medical (WMGI) Down 3.1% Since Earnings Report: Can It Rebound?
    Zacks18 days ago

    Wright Medical (WMGI) Down 3.1% Since Earnings Report: Can It Rebound?

    WMGI reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Wright Medical (WMGI) Posts Wider-than-Expected Loss in Q1
    Zacks2 months ago

    Wright Medical (WMGI) Posts Wider-than-Expected Loss in Q1

    Wright Medical Group N.V. (WMGI) reported adjusted loss of 9 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 8 cents.

  • American City Business Journals2 months ago

    Wright Medical reports net loss, optimism for year ahead

    A global medical device company with corporate headquarters in Memphis reported a net loss for the quarter but optimism and growth for the rest of the year. The net loss included the after-tax effects of $3 million of transition costs, an unrealized loss of $400,000 related to mark-to-market adjustments on derivatives, $11 million of non-cash interest expense related to its convertible notes, and a $6.2 million unrealized loss related to mark-to-market adjustments on contingent value rights (CVRs) issued in connection with its 2012 acquisition of BioMimetic Therapies. Wright Medical Group anticipates net sales for the year to be about $755 million, or an increase of about 9 to 11 percent.